Background The large number of patients worldwide infected with the SARS-CoV-2 virus
has overwhelmed health-care systems globally. The Anti-Coronavirus Therapies (ACT) …

Background COVID-19 disease is accompanied by a dysregulated immune response and
hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate …

Background Evidence suggests a role for excessive inflammation in COVID-19
complications. Colchicine is an oral anti-inflammatory medication beneficial in gout …

Background Colchicine has been proposed as a treatment for COVID-19 based on its anti-
inflammatory actions. We aimed to evaluate the efficacy and safety of colchicine in patients …

Background Colchicine was recently repurposed for the management of coronavirus
disease 2019 (COVID‐19). This rapid review and meta‐analysis aimed to assess …

Introduction Colchicine, because of its anti-inflammatory and possible anti-viral properties,
has been proposed as potential therapeutic option for COVID-19. The role of colchicine to …

Aim This meta-analysis aimed to assess the usefulness of colchicine in patients with COVID-
19. Methods PubMed, Web of Science, Ovid MEDLINE, the Cochrane Library, Embase, and …

Introduction Colchicine may inhibit inflammasome signaling and reduce proinflammatory
cytokines, a purported mechanism of COVID-19 pneumonia. The aim of this systematic …

Background Colchicine is an available, safe, and effective anti-inflammatory drug and has
been suggested as a COVID-19 treatment, but its usefulness in hospitalized severe COVID …

Background Colchicine has been proposed as a potential therapy in coronavirus disease
2019 (COVID-19) due to their anti-inflammatory actions. Methods The COL-COVID study …